The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with β-blockade

A. Kelley-Hedgepeth; I. Peter; K. E. Kip; M. C. Montefusco; S. Kogan; D. Cox; J. M. Ordovas; D. Levy; S. E. Reis; M. E. Mendelsohn; D. Housman; G. S. Huggins

doi:10.1038/jhh.2008.23

The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with β-blockade

A. Kelley-Hedgepeth, I. Peter, K. E. Kip, M. C. Montefusco, S. Kogan, D. Cox, J. M. Ordovas, D. Levy, S. E. Reis, M. E. Mendelsohn, D. Housman, G. S. Huggins

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Original language	English
Pages (from-to)	512-515
Number of pages	4
Journal	Journal of Human Hypertension
Volume	22
Issue number	7
DOIs	https://doi.org/10.1038/jhh.2008.23
State	Published - Jul 2008
Externally published	Yes

Access to Document

10.1038/jhh.2008.23

Cite this

Kelley-Hedgepeth, A., Peter, I., Kip, K. E., Montefusco, M. C., Kogan, S., Cox, D., Ordovas, J. M., Levy, D., Reis, S. E., Mendelsohn, M. E., Housman, D., & Huggins, G. S. (2008). The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with β-blockade. Journal of Human Hypertension, 22(7), 512-515. https://doi.org/10.1038/jhh.2008.23

@article{f031e7aaf9de41ccb6e0a9acd9aef4d9,

title = "The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with β-blockade",

author = "A. Kelley-Hedgepeth and I. Peter and Kip, {K. E.} and Montefusco, {M. C.} and S. Kogan and D. Cox and Ordovas, {J. M.} and D. Levy and Reis, {S. E.} and Mendelsohn, {M. E.} and D. Housman and Huggins, {G. S.}",

note = "Funding Information: This project is funded, in part, under a grant with the Pennsylvania Department of Health (SER) (contract no. ME-02-384). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. This project was supported by the National Institutes of Health program project Grant no. HL077378 and training grant no. HL069770 (MEM). This work was supported by the National Heart, Lung and Blood Institute{\textquoteright}s Framing-ham Heart Study (contract no. N01-HC-25195) and Boston University School of Medicine.",

year = "2008",

month = jul,

doi = "10.1038/jhh.2008.23",

language = "English",

volume = "22",

pages = "512--515",

journal = "Journal of Human Hypertension",

issn = "0950-9240",

publisher = "Springer Nature",

number = "7",

}

TY - JOUR

T1 - The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with β-blockade

AU - Kelley-Hedgepeth, A.

AU - Peter, I.

AU - Kip, K. E.

AU - Montefusco, M. C.

AU - Kogan, S.

AU - Cox, D.

AU - Ordovas, J. M.

AU - Levy, D.

AU - Reis, S. E.

AU - Mendelsohn, M. E.

AU - Housman, D.

AU - Huggins, G. S.

N1 - Funding Information: This project is funded, in part, under a grant with the Pennsylvania Department of Health (SER) (contract no. ME-02-384). The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. This project was supported by the National Institutes of Health program project Grant no. HL077378 and training grant no. HL069770 (MEM). This work was supported by the National Heart, Lung and Blood Institute’s Framing-ham Heart Study (contract no. N01-HC-25195) and Boston University School of Medicine.

PY - 2008/7

Y1 - 2008/7

UR - http://www.scopus.com/inward/record.url?scp=45849116481&partnerID=8YFLogxK

U2 - 10.1038/jhh.2008.23

DO - 10.1038/jhh.2008.23

M3 - Article

C2 - 18418400

AN - SCOPUS:45849116481

SN - 0950-9240

VL - 22

SP - 512

EP - 515

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

IS - 7

ER -